Wednesday, February 17, 2016

"Because [Gilead Sciences Inc.'s] drugs offer a cure ...

... for a serious and life-threatening infectious disease, pricing the treatment in a manner that effectively allows [the hepatitis C virus] to continue spreading through vulnerable populations, as opposed to eradicating the disease altogether, results in massive public harm."

— Massachusetts Attorney General Maura Healey (D) said in a Jan. 22 letter asking the drugmaker to reconsider its pricing strategy for Harvoni and Sovaldi.

No comments:

Post a Comment